Profile photo Miriam Koopman

Miriam Koopman

Full Professor

Strategic program(s):

Strategic program(s):

Contact

Recent publications

Harnessing the Potential of Real-World Evidence in the Treatment of Colorectal Cancer Sietske C M W van Nassau, Guus M Bol, Frederieke H van der Baan, Jeanine M L Roodhart, Geraldine R Vink, Cornelis J A Punt, Anne M May, Miriam Koopman, Jeroen W G Derksen
Current treatment options in oncology, 2024, vol. 25, p.405-426
Trastuzumab deruxtecan in HER2-positive metastatic colorectal cancer Jeanine M.L. Roodhart, Miriam Koopman
The Lancet Oncology, 2024, vol. 25, p.1104-1105
Discovering novel germline genetic variants linked to severe fluoropyrimidine-related toxicity in- and outside DPYD Jonathan E. Knikman, Qinglian Zhai, Carin A.T.C. Lunenburg, Linda M. Henricks, Stefan Böhringer, Maaike van der Lee, Femke M. de Man, Steven M. Offer, Shikshya Shrestha, Geert Jan Creemers, Arnold Baars, Vincent O. Dezentjé, Alexander L.T. Imholz, Frank J.F. Jeurissen, Johanna E.A. Portielje, Rob L.H. Jansen, Paul Hamberg, Helga J. Droogendijk, Miriam Koopman, Peter Nieboer, Marlène H.W. van de Poel, Caroline M.P.W. Mandigers, Ron H.N. van Schaik, Hans Gelderblom, Ron H.J. Mathijssen, Jan H.M. Schellens, Annemieke Cats, Henk Jan Guchelaar, Jesse J. Swen
Genome Medicine, 2024, vol. 16
Results from the UNITED study M. Polack, M. A. Smit, G. W. van Pelt, A. G.H. Roodvoets, E. Meershoek-Klein Kranenbarg, Hein Putter, H. Gelderblom, A. S.L.P. Crobach, V. Terpstra, G. Petrushevska, G. Gašljević, S. Kjær-Frifeldt, E. M.V. de Cuba, N. W.J. Bulkmans, Geraldine R. Vink, R. Al Dieri, R. A.E.M. Tollenaar, J. H.J.M. van Krieken, W. E. Mesker, Gordana Petrushevska, Magdalena Bogdanovska, Panche Zdravkoski, Svetozar Antovic, Darko Dzambaz, Panche Karagjozov, Erienne M.V. de Cuba, Frédérique Beverdam, Jan Jansen, Maarten Vermaas, Gorana Gašljević, Sanne Kjær-Frifeldt, Jan Lindebjerg, Maud Strous, Jeroen F. Vogelaar, Nicole W.J. Bulkmans, Joop van Baarlen, Leonie Mekenkamp, Ronald Hoekstra, Mark Sie, Miriam Cuatrecasas, Sara Simonetti, María Teresa Rodrigo, Iván Archilla Sanz, Jose Guerrero Pineda, Miangela M. Lacle, Miriam Koopman, Jan Willem T. Dekker, René Arensman, M. Polack,
ESMO open, 2024, vol. 9
Prognostic value of liver metastases in colorectal cancer treated by systemic therapy Romain Cohen, Morteza Raeisi, Benoist Chibaudel, Qian Shi, Takayuki Yoshino, John R. Zalcberg, Richard Adams, Chiara Cremolini, Eric Van Cutsem, Volker Heinemann, Josep Tabernero, Cornelis J.A. Punt, Dirk Arnold, Herbert I. Hurwitz, Jean Yves Douillard, Alan P. Venook, Leonard B. Saltz, Timothy S. Maughan, Fairooz Kabbinavar, Carsten Bokemeyer, Axel Grothey, Robert J. Mayer, Richard Kaplan, Niall C. Tebbutt, J. Randolph Hecht, Bruce J. Giantonio, Eduardo Díaz-Rubio, Alberto F. Sobrero, Marc Peeters, Miriam Koopman, Richard M. Goldberg, Thierry Andre, Aimery de Gramont
European Journal of Cancer, 2024, vol. 207
Survival and patient-reported outcomes of real-world high-risk stage II and stage III colon cancer patients after reduction of adjuvant CAPOX duration from 6 to 3 months Ingrid A. Franken, Frederieke H. van der Baan, Geraldine R. Vink, Anne M. May, Wilhelmina M.U. van Grevenstein, Miriam Koopman, Jeanine M.L. Roodhart
European Journal of Cancer, 2024, vol. 208